TRPC1 and Parkinson disease: Specific blockade of TRPC1 and TRPC5 inhibited ERK/cAMP response element binding protein activation and provided neuroprotection.426 TRPCs have also been linked to Parkinson’s disease (PD) and Alzheimer’s disease (AD).